Kidney Stone Treatment Devices Market Size and Forecast Analysis 2017-2021

Kidney stone or nephrolithiasis has been one of the most common disorders and has introduced negligible innovation in the past few years. The global kidney stone treatment devices market is anticipated to grow only at a moderate pace through the forecast period. Advances in electronics and integration of the technology in healthcare have become a common trend. Miniaturized devices with easy and convenient handling have reduced the need of hospital visits to a large extent. However, nephrolithiasis remains deprived of breakthrough research. This lack of innovation and technology upgrade limits the growth of kidney stone treatment devices market.

Extracorporeal shock wave lithotripsy is currently the most common method for treatment of kidney stones or renal calculi. The process is non-invasive and painless, and allows quick recovery which makes it a preferred treatment choice. Other well-known technologies in the kidney stone treatment devices market include endoscopes that allow physicians to remove kidney stones through non-invasive and minimally invasive procedures. However these endoscopic procedures are generally preferred in severe cases. The kidney stone treatment devices market received traction due to advent of mobile units that carry lithotripsy devices to patient bedside. This trend is more common in North America and Europe, and stays impeded in other developing and underdeveloped countries due to logistic issues and small number of procedures to justify return on investment. Healthcare authorities in developing and under developed countries in Asia, Latin America and Africa are mostly inclined towards purchase of refurbished devices at low cost due to financial pressure. Institutes choosing new devices have a preference for mobile devices with flexibility to move to other procedure rooms. In spite of these factors the overall kidney stone treatment devices market is growing fast in Asia Pacific and Latin America region as compared to other regions.

Report Sample@ http://www.sa-brc.com/Global-Kidney-Stone-Treatment-Devices-Market-Assessment--Forecast-2017-2021/up84

Currently SonoMotion is developing a non-invasive treatment alternative for treatment of kidney stone. The Break Wave device is claimed to fragment large kidney stones faster as compared to other existing alternatives. Stone Clear is another device currently under clinical trials for treatment of nephrolithiasis. Such new device would define the future of kidney stone treatment devices market.

Large numbers of hospital visits are recorded for people suffering from kidney stone globally. Data published by the National Kidney and Urologic Diseases Information Clearinghouse states that 13% men and 7% women in the U.S. have at least one incidence of kidney stone. While 15% men in and over 10% women in U.K. develop kidney stone at least once in their life span. Such high prevalence and higher chances of recurrence drives the global kidney stone treatment devices market. Data published by the European Union mentions that Bulgaria, Cyprus, Slovakia, Croatia and Poland recorded highest number of extracorporeal shock wave lithotripsy units in 2014. The data however does not mention details for major European Union economies including Germany, France, Italy, and Sweden.

Click For TOC@ http://www.sa-brc.com/Global-Kidney-Stone-Treatment-Devices-Market-Assessment--Forecast-2017-2021/upcomingdetail84

Key players in the kidney stone treatment devices market include Boston Scientific Corp., Cook Medical, Direx Group, ENDO-FLEX GmbH, Olympus, Siemens AG, and Storz Medical AG, among others.

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701
Email: sales@sa-brc.com
Website: www.sa-brc.com

This release was published on openPR.